The FDA’s long-await­ed ex­pe­dit­ed in­ves­ti­ga­tion­al new drug pi­lot pro­gram be­gan ac­cept­ing ap­pli­ca­tions Tues­day, with top agency of­fi­cials in­cor­po­rat­ing pub­lic feed­back in­to who should qual­i­fy.

Karim...

The French biotech Ax­oltis Phar­ma re­port­ed a Phase 2 fail­ure in ALS on Tues­day morn­ing, but sug­gest­ed it found a small sig­nal to move the...

Sion­na Ther­a­peu­tics an­nouncedit was lay­ing off 46% of its staff as it seeks a way for­ward fol­low­ing an un­ex­pect­ed tri­al fail­ure in cys­tic fi­bro­sis...

As the FDA ramps up its ef­fort to ac­cel­er­ate the de­vel­op­ment of psy­che­del­ic ther­a­pies, men­tal health ex­perts on Mon­day urged the agency to con­sid­er cer­tain...